Incyte
Buying intent
116 tracked signals | Top 15 topics are below | Marketing and Data are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Incyte's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
2d ago
15d ago
15d ago
10d ago
15d ago
26d ago
15d ago
17d ago
19d ago
26d ago
26d ago
15d ago
10d ago
18d ago
20d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Incyte
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
49 people across every department at Incyte, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileIncyte is focused on advancing biopharmaceutical innovation. Founded in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments across Hematology, Oncology and Inflammation and Autoimmunity. Today, the company has more than 2,800 employees and operations in 13 countries across North
New capability sought
Employee posts (LinkedIn)Drug Development; Johnson & Johnson; Pharmaceutical; Sales Training; Talent Management; Conference; Healthcare Providers; Oncology
Top accounts researching Incyte
names withheld on the public pageThese are companies whose own people brought up Incyte unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
75,708 companies · 411,263 people are researching Hiring
Incyte's own team shows 9 signals on this topic. No one outside Incyte has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Clinical Trials4,086 cos · 17,225 people
- Artificial Intelligence151,426 cos · 839,012 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 7 people; Marketing — 4 people; Leadership — 4 people; HR / Talent — 3 people; Data / Analytics — 1 person; IT — 1 person; Product — 1 person; Engineering — 1 person
What's been said
public posts mentioning IncyteUp to 9 public excerpts naming Incyte from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
I wanted to take a moment to reflect on our recent Jakafi XR launch meeting, where "The Incyte MPN Team" and our business partners came together in an energizing and collaborative environment. It was truly inspiring to witness everyone mastering the data, sharpening their selling skills, and engaging in dynamic learning from one another. The dedication and commitment displayed was championship level. The best teams always draw their confidence from their competence. I'd like to extend my heartfelt gratitude to the sales training department, sales leaders, marketing team, regional trainers, and the many business partners who worked tirelessly behind the scenes to make this event such a success. Your efforts not only helped us prepare for the launch but also brought out the best in our team and our shared commitment to excellence. At Incyte, our focus remains on solving for patients, and moments like these remind me of the power of teamwork and perseverance. Thank you all for your hard work. Now let’s do the important work to Solve On for patients!
May 2026Strategic priorities
Earnings call; SEC filingsSales Operations; Market Access; @RISK
Budget pressure / cost-cutting signal
Earnings call; SEC filingsCost of Revenue: 10,45,23,000 USD
What changed recently
Earnings call; SEC filingsSales Operations; Market Access; @RISK